691 reports of this reaction
2.1% of all OXYCODONE HCL reports
#5 most reported adverse reaction
DYSPNOEA is the #5 most commonly reported adverse reaction for OXYCODONE HCL, manufactured by Amneal Pharmaceuticals NY LLC. There are 691 FDA adverse event reports linking OXYCODONE HCL to DYSPNOEA. This represents approximately 2.1% of all 32,776 adverse event reports for this drug.
Patients taking OXYCODONE HCL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for OXYCODONE HCL, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for OXYCODONE HCL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 691 FDA reports for OXYCODONE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.1% of all adverse event reports for OXYCODONE HCL, making it a notable side effect.
If you experience dyspnoea while taking OXYCODONE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.